23 results for author:"La Du B.N." in Literature citations
Results Customize
› Repeat search in UniProtKB (19)
| Estrogen esters as substrates for human paraoxonases. Teiber J.F., Billecke S.S., La Du B.N., Draganov D.I. Arch. Biochem. Biophys. 461:24-29(2007) · Mapped (5) |
| Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. Draganov D.I., Teiber J.F., Speelman A., Osawa Y., Sunahara R., La Du B.N. J. Lipid Res. 46:1239-1247(2005) · UniProtKB (3) · Mapped (10) |
| Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3. Teiber J.F., Draganov D.I., La Du B.N. Biochem. Pharmacol. 66:887-896(2003) · Mapped (3) |
| Rabbits possess a serum paraoxonase polymorphism similar to the human Q192R. Watson C.E., Draganov D.I., Billecke S.S., Bisgaier C.L., La Du B.N. Pharmacogenetics 11:123-134(2001) · UniProtKB (1) |
| Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. Draganov D.I., Stetson P.L., Watson C.E., Billecke S.S., La Du B.N. J. Biol. Chem. 275:33435-33442(2000) · UniProtKB (1) |
| Human serum paraoxonase/arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity. Sorenson R.C., Bisgaier C.L., Aviram M., Hsu C., Billecke S., La Du B.N. Arterioscler. Thromb. Vasc. Biol. 19:2214-2225(1999) · UniProtKB (1) |
| Characterization of an unstable variant (BChE115D) of human butyrylcholinesterase. Primo-Parmo S.L., Lightstone H., La Du B.N. Pharmacogenetics 7:27-34(1997) · UniProtKB (1) |
| Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. Navab M., Hama-Levy S., Van Lenten B.J., Fonarow G.C., Cardinez C.J., Castellani L.W., Brennan M.L., Lusis A.J., Fogelman A.M., La Du B.N. J. Clin. Invest. 99:2005-2019(1997) · Mapped (7) |
| The genetic mapping and gene structure of mouse paraoxonase/arylesterase. Sorenson R.C., Primo-Parmo S.L., Camper S.A., La Du B.N. Genomics 30:431-438(1995) · Mapped (3) |
| The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Primo-Parmo S.L., Sorenson R.C., Teiber J., La Du B.N. |
| Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene. Primo-Parmo S.L., Bartels C.F., Wiersema B., van der Spek A.F.L., Innis J.W., La Du B.N. Am. J. Hum. Genet. 58:52-64(1996) · UniProtKB (1) |
| Studies on human serum paraoxonase/arylesterase. La Du B.N., Adkins S., Kuo C.L., Lipsig D. Chem. Biol. Interact. 87:25-34(1993) · UniProtKB (1) |
| Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Adkins S., Gan K.N., Mody M., La Du B.N. Am. J. Hum. Genet. 52:598-608(1993) · UniProtKB (1) |
| Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. Sorenson R.C., Primo-Parmo S.L., Kuo C.-L., Adkins S., Lockridge O., La Du B.N. Proc. Natl. Acad. Sci. U.S.A. 92:7187-7191(1995) · UniProtKB (2) · Mapped (2) |
| Brain cDNA clone for human cholinesterase. McTiernan C., Adkins S., Chatonnet A., Vaughan T.A., Bartels C.F., Kott M., Rosenberry T.L., la Du B.N., Lockridge O. Proc. Natl. Acad. Sci. U.S.A. 84:6682-6686(1987) · UniProtKB (1) |
| Location of disulfide bonds within the sequence of human serum cholinesterase. Lockridge O., Adkins S., la Du B.N. J. Biol. Chem. 262:12945-12952(1987) · UniProtKB (1) |
| Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase. McGuire M.C., Nogueira C.P., Bartels C.F., Lightstone H., Hajra A., van der Spek A.F.L., Lockridge O., la Du B.N. Proc. Natl. Acad. Sci. U.S.A. 86:953-957(1989) · UniProtKB (1) · Mapped (1) |
| Structure of the gene for human butyrylcholinesterase. Evidence for a single copy. Arpagaus M., Kott M., Vatsis K.P., Bartels C.F., la Du B.N., Lockridge O. Biochemistry 29:124-131(1990) · UniProtKB (1) |
| Use of the polymerase chain reaction for homology probing of butyrylcholinesterase from several vertebrates. Arpagaus M., Chatonnet A., Masson P., Newton M., Vaughan T.A., Bartels C.F., Nogueira C.P., la Du B.N., Lockridge O. J. Biol. Chem. 266:6966-6974(1991) · UniProtKB (7) |
| Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Gan K.N., Smolen A., Eckerson H.W., La Du B.N. Drug Metab. Dispos. 19:100-106(1991) · UniProtKB (1) |
| Identification of two different point mutations associated with the fluoride-resistant phenotype for human butyrylcholinesterase. Nogueira C.P., Bartels C.F., McGuire M.C., Adkins S., Lubrano T., Rubinstein H.M., Lightstone H., Van Der Spek A.F.L., Lockridge O., La Du B.N. Am. J. Hum. Genet. 51:821-828(1992) · UniProtKB (1) |
| DNA mutations associated with the human butyrylcholinesterase J-variant. Bartels C.F., James K., La Du B.N. Am. J. Hum. Genet. 50:1104-1114(1992) · UniProtKB (1) · Mapped (2) |
| Structural basis of the butyrylcholinesterase H-variant segregating in two Danish families. Jensen F.S., Bartels C.F., La Du B.N. Pharmacogenetics 2:234-240(1992) · UniProtKB (1) |